Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board is in the process of awarding a contract for Primary Care Enhanced Services, which includes various general-practitioner services such as phlebotomy, minor injuries, and specialised drug monitoring. This procurement falls under the healthcare services sector and is guided by the Provider Selection Regime Regulations 2023, with contract operations expected from 1st April 2025 to 31st March 2026. The intent notice was published on 3rd September 2025, marking the onset of a standstill period.
Representations by providers should be submitted by 15th September 2025. The contract, valued at £25,605, will take place in the UKF3 region. The procurement uses a limited award procedure without prior publication of a call for competition, indicating the absence of viable alternatives through open procedures.
This tender presents considerable opportunities for SMEs in the healthcare sector, particularly those with expertise in primary care and the ability to integrate innovative healthcare solutions. Businesses that excel in service quality, integration, and social value are well-positioned to benefit from such contracts. The contracting authority, NHS Lincolnshire Integrated Care Board, places great emphasis on sustainability, health equality improvements, and collaboration, making it crucial for businesses to align with these objectives.
Engaging with such opportunities could foster business growth through the expansion of service offerings and visibility within the highly relevant public health landscape.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Spirometry - Minor Injuries - DVT Assessment & Management including D-Dimer Testing - Routine 12 Lead ECG - 24hr ABPM. The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS25,605. The provider is an existing provider and the services are existing services.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us